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Invasive pneumococcal disease in adults in
North-Rhine Westphalia, Germany
10.1111/j.1469-0691.2006.01518.x
The recent paper in CMI by Reinert et al. [1]
presented interesting information on invasive
pneumococcal disease in adults in North-Rhine
Westphalia, Germany, which was collected pro-
spectively. It was reported that blood cultures
were obtained in 464 cases, and that 152 of these
(only 11 grew Streptococcus pneumoniae) were
positive. However, no information was provided
concerning the 141 non-pneumococci isolates.
These data are of extreme importance, as hardly
any data concerning bacteraemic community-
acquired pneumonia are available. It was also
reported that 112 of 464 patients were receiving
antibiotic treatment when the blood cultures were
inoculated. It would be interesting to know how
many of these 112 blood cultures were positive
and which pathogens were cultured.
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Our prospective population-based survey [1] of
invasive pneumococcal disease (IPD) among
adults in North-Rhine Westphalia, Germany,
included 202 of the 386 hospitals in the region,
and the 27 microbiological laboratories that sub-
mitted reports of IPD in these hospitals to the
National Reference Centre for Streptococci
(NRCS). In addition, the degree of under-report-
ing in this region was evaluated. All 27 laborat-
ories were asked to provide complete laboratory
records on all cases of IPD, and 16 were able to do
so. Data concerning all IPD isolates sent by each
of these 16 laboratories to the NRCS were linked
to the databases of each laboratory’s information
system. Moreover, in two additional studies, the
frequency of obtaining blood cultures, as well as
the incidence of previous antibiotic therapy, was
analysed in patients with community-acquired
pneumonia (CAP). For the year 2000, the fre-
quency of obtaining blood cultures was deter-
mined for patients admitted to three university
hospitals (Aachen, Du¨sseldorf and Cologne) with
CAP. In addition, in 2001, the frequency of
antibiotic treatment before blood cultures were
obtained from CAP patients was determined by a
detailed analysis of patient histories. As outlined
in our paper in CMI [1], all cases with the
diagnosis of CAP (all diagnostic positions on the
discharge summary) were identified retrospec-
tively on the basis of ICD-10 codes (J13, J15.9,
J18.0, J18.9). Cases were linked with data in the
laboratory information systems of each hospital’s
microbiological laboratory.
Outcome data were obtained for all patients
from the discharge files of the individual hospi-
tals. Therefore, we are not able to provide the
prospective data requested by Professor Shah.
However, we would like to share the retrospec-
tive data for the 152 cases with positive blood
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cultures. As only two of the three university
hospitals had a laboratory information system in
the year 2000, the complete data were available
only for these two hospitals (the third hospital
only provided data concerning the number of
positive blood cultures and the number that were
positive for Strep. pneumoniae) (Table 1). Table 2
summarises the data for the other organisms
isolated in the two hospitals that provided these
data, with Staphylococcus epidermidis identified in
35.4% of cases, Staphylococcus aureus in 10%, and
Gram-negative bacteria in 24.5%. Of note, as we
focused on pneumococcal infections, the
Staph. epidermidis cases were not analysed to
determine the clinical relevance of the pathogen.
Moreover, the 464 cases with antibiotic treatment
for positive blood cultures and pathogens were
not analysed separately, but we agree that these
data would be interesting. The data from an
ongoing study will be analysed for these details
and we hope to present these data in the future.
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Use of molecular techniques for
epidemiological typing of rapidly growing
mycobacteria
10.1111/j.1469-0691.2006.01538.x
We read with interest the article in CMI by
Sampaio et al. [1], which described the use of
different methods for epidemiological typing of
rapidly growing mycobacteria. We agree with
the authors that molecular epidemiology is a
basic tool for gaining a better understanding of
the epidemiology of these organisms and their
role in human disease. However, the authors
stated that the randomly amplified polymorphic
DNA (RAPD) technique has a lower discrimi-
native power than ERIC-PCR or pulsed-field gel
electrophoresis (PFGE). This is not consistent
with our own recent experience in this area.
RAPD is a technique that has been described
for use with many species of bacteria, including
rapidly growing mycobacteria [2]. This tech-
nique has well-known problems concerning
reproducibility that have been described else-
where [3], but these problems can be addressed
by analysing all isolates on the same gel, and by
performing the experiments under rigorously
standardised conditions. The discriminative
power of the technique depends not only on
the primer set employed in the study [2], but
also on the number of primers used. In our own
experience using several primer sets [4], the
only isolates that give identical electrophoretic
profiles with at least three primer sets are those
that are epidemiologically related. If isolates are
analysed with only one primer set, there could
be false clustering of isolates that are epidem-
iologically unrelated, but these false clusters
disappear if additional primer sets are used.
Such an approach has been used in several
studies and has generated excellent results [5,6].
Sampaio et al. [1] used only one primer set, but
a combination of several primer sets may have
generated RAPD results that were at least
comparable with those of ERIC-PCR or PFGE.
The authors stated that other primer sets were
used, and it would be interesting to know
Table 2. Bacteria isolated from blood cultures of patients
with community-acquired pneumonia
Hospital 1 Hospital 2 Total
n % n % n %
Patients 302 494
Mortality 47 15.6% 70 14.2%
Blood cultures 168 55.6% 228 46.2%
Positive blood cultures 53 31.5% 57 25.0%
Bacteria isolated
Gram-negative bacteria 14 26.4% 13 22.8% 27 24.5%
Staphylococcus epidermidis 19 35.8% 20 35.1% 39 35.4%
Staphylococcus aureus 8 15.1% 3 5.3% 11 10.0%
Streptococcus pneumoniae 4 7.5% 2 3.5% 6 5.5%
Others 9 17.0% 15 26.3% 24 21.8%
Table 1. Blood cultures in three university hospitals in
North-Rhine Westphalia
Hospital Patients
Blood
cultures
Positive
blood
cultures
Blood cultures
positive for
Streptococcus
pneumoniae
1 302 168 53 2
2 494 228 57 4
3a 458 68 42 5
Total 1254 464 152 11
aHospital 3 provided data only for the number of positive blood cultures and the
number that were positive for Strep. pneumoniae.
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